15. - 19.03.2020 | SOT 2020
Conference Venue: Anaheim Convention Center, Anaheim, California, USA
Go to the Conference website here.
Meet Marta Lemme from Nanion Technologies Munich at the Conference.
Marta will give an oral presentation.
Date: Tuesday, 17th March, 4:30 PM- 5:30 PM.
Location: Room 206A
Session: "Cross-Platform Validation of Human iPS Cell-Derived Cardiomyocytes in Toxicity Screening Applications". Presented by NEXEL Co. Ltd.
A critical component of the CiPA initiative is the iPSC-derived cardiomyocyte assay. We performed drug screening assays using NEXEL's Cardiosight-S on a variety of platforms from Nanion Technologies (CardioExcyte 96, FLEXcyte 96 and Patchliner Dynamite8). Cardiac toxicity of CiPA panel compounds were predicted accurately, validating the cells and platforms.